Expanded Access Program for Epcoritamab
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
- Status
- RECRUITING
- Phase
- PHASE3
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
Venetoclax After TKI to Target Persisting Stem Cells in CML
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Expanded Access to Epcoritamab
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study to Assess Adverse Events and How Single and Multiple Ascending Doses of ABBV-903 Move Through the Body in Healthy Adults
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants
- Status
- COMPLETED
- Phase
- N/A
A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional Constipation
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate Satisfaction in Adult Participants With the Aesthetics of the Periorbital Area After JUVÉDERM® Fillers and BOTOX®/VISTABEL® Injections
- Status
- COMPLETED
- Phase
- PHASE4
A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's Disease
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
- Status
- COMPLETED
- Phase
- PHASE2
Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact Lenses
- Status
- WITHDRAWN
- Phase
- PHASE4
Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study to Assess Change in Disease Activity and Adverse Events of RINVOQ in Adult Participants With Ankylosing Spondylitis in the Real-World Japan
- Status
- COMPLETED
- Phase
- N/A
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Status
- RECRUITING
- Phase
- PHASE3